Therapeutic uses of glandular kallikrein
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 27, 2007
Grant Date -
Nov 20, 2003
app pub date -
Jun 6, 2002
filing date -
Jun 6, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
An immunosuppressive peptide of 40 kDa molecular weight, isolated from the submandibular glands (SMG*) of rats, had the capacity to suppress immune reactions upon parenteral administration to rats and mice. The peptide was identified as glandular kallikrein (K1) by partial sequencing and by enzymatic activity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully